Centers for Disease Control and Prevention (CDC), Procurement and Grants Office, FCC & E Section, Mailstop (K71), 2920 Brandywine Road, Atlanta, GA 30341-4146

65 -- SMALLPOX VACCINE STOCKPILE MAINTENANCE POC Rex Ellington, Contract Specialist, (770) 488-2615 The Centers for Disease Control & Prevention intends to negotiate with Wyeth-Lederle Vaccines & Pediatrics on a sole source basis for modification of CDC's existing Smallpox vaccine stockpile contract to provide for the production of additional vaccinia diluent and bifurcated needles. Authority: 41 U.S.C.253 (c)(1), products are available from only one responsible source. Diluent -- 150,000 single use vials for the reconstitution of Wyeth's Dryvax (Smallpox vaccine dried calf lymph type). Each vial of diluent must be capable of reconstituting one 100-dose vial of Dryvax. Bifurcated needles -- fourteen million needles with appropriate storage containers for proper application of the Dryvax vaccine. Both the diluent and bifurcated needles must be approved and licensed by the U.S. Food and Drug Administration for use with Dryvax vaccine. A solicitation will not be issued for this acquisition. Interested sources that believe they can meet the requirements should respond to this notice within 15 calendar days and provide evidence of FDA approval for the production of Dryvax diluent and bifurcated needles. Posted 02/17/99 (I-SN299146). (0048)

Loren Data Corp. http://www.ld.com (SYN# 0392 19990219\65-0003.SOL)